RxDoctor Payments Data

Johanna Weir, PA

Medical · Bartlesville, OKNPI 1740499730

Payments from drug & device makers

$414in general payments, 2019–2025

Across 24 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$115
  • Pfizer$57
  • AstraZeneca$56
  • Novo Nordisk$41
  • Abbott$37
  • Lilly USA, LLC$31
  • plus $79 from 4 others

What the payments were for

  • Food & beverage$414100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$414 in reported general payments places this provider in the 50th percentile of 370 medical providers in Oklahoma.

See all medical providers in Oklahoma

Medicare billing

Part B allowed, 2024
$40,605
Medicare patients
154
Services billed
915

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide48$43,491
MounjaroTirzepatide28$30,197
TrulicityDulaglutide28$27,826
JardianceEmpagliflozin18$25,460
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog21$20,062
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog18$16,421
VraylarCariprazine Hcl11$15,362
XareltoRivaroxaban12$14,135
Tresiba Flextouch U-100Insulin Degludec24$10,895
JanuviaSitagliptin Phosphate22$10,700
EliquisApixaban13$8,336
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,819
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,010
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$3,930
Novolog FlexpenInsulin Aspart11$2,797

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$31$58,02356 claims
Novo NordiskOzempic$41$43,49148 claims
AbbVieVraylar, Synthroid$115$15,84223 claims
PfizerEliquis$57$8,33613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 370 medical providers in Oklahoma.

Other medical in Bartlesville

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →